CYSTADROPS
cysteamine hydrochloride
- Strength
- 3.5 mg/mL
- Form
- Solution
- Class
- Cystine Depleting Agent
RECORDATI RARE DISEASES, INC.
Not stocked by us — reference only
Cysteamine bitartrate
Listed by Horizon Therapeutics USA, Inc.
| Dosage form | Capsule, Delayed Release Pellets |
|---|---|
| Route | Oral |
| Drug class | Cystine Depleting Agent |
| Approval route | NDA — original brand approval |
| NDC code | 75987-100 |
| FDA application | NDA203389 |
| RxNorm concept | 1421467 |
| Package sizes listed | 1 |
| Marketed since | April 2013 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
cysteamine hydrochloride
RECORDATI RARE DISEASES, INC.
Not stocked by us — reference only
cysteamine bitartrate
Mylan Pharmaceuticals Inc.
Not stocked by us — reference only
cysteamine bitartrate
Mylan Pharmaceuticals Inc.
Not stocked by us — reference only
cysteamine hydrochloride
Leadiant Biosciences, Inc.
Not stocked by us — reference only
cysteamine hydrochloride
Leadiant Biosciences, Inc.
Not stocked by us — reference only
Cysteamine bitartrate
Horizon Therapeutics USA, Inc.
Not stocked by us — reference only
Cysteamine bitartrate
Horizon Therapeutics USA, Inc.
Not stocked by us — reference only
Cysteamine bitartrate
Horizon Therapeutics USA, Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.